Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors - Related Studies

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

This study is ongoing, but not recruiting participants.

Study NCT00003515. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Sarcoma

2	Additional conditions recognized in this trial
		Neuroectodermal Tumors
		Neuroectodermal Tumors, Primitive

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Connective and Soft Tissue
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial

4	Interventions listed in this trial
		antineoplaston A10
		antineoplaston AS2-1

5	Sponsors listed in this trial
		Burzynski Research Institute